Global Travel Vaccines Market 2016-2020

トラベルワクチンの世界市場2016-2020:単価ワクチン、混合ワクチン

◆タイトル:Global Travel Vaccines Market 2016-2020
◆商品コード:IRTNTR10903
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2016年11月24日
◆ページ数:60
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、トラベルワクチンの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、トラベルワクチンの世界市場規模及び予測、疾患種類別分析、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Travel VaccinesAs the world continues to move toward globalization, the international travels will keep increasing. This fuels the demand for travel vaccines as the prevalence of infectious diseases are specifically region prone, unlike that of other indications. As vaccines are largely used as a preventive measure against these known infectious diseases, the travelers are advised to follow the region-specific immunization plan. The market is growing because various government bodies have mandated the immunization of travelers visiting the infectious-prone areas with various types of vaccines. This, in turn, prevents the spread of infection and averts any chances of epidemic outbreaks.

Technavio’s analysts forecast the global travel vaccines market to grow at a CAGR of 6.83% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global travel vaccines market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various vaccines administered to actively immunize meningococcal disease, Japanese encephalitis, rabies, typhoid, yellow fever, hepatitis B, and hepatitis A. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Travel Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• GlaxoSmithKline
• Merck
• Pfizer
• Sanofi

[Other prominent vendors]
• Abbott
• AstraZeneca
• Bavarian Nordic
• Baxter
• Beijing Minhai Biotechnology
• Bharat Biotech
• Bharat Immunologicals and Biologicals
• Bio-Med
• Seqirus CSL
• Crucell
• CSL
• Dynavax Technologies
• Emergent BioSolutions
• GlycoVaxyn
• GreenSignal Bio Pharma
• Hualan Biological Engineering
• Imunoloski Zavod
• Indian Immunologicals
• Janssen Pharmaceuticals
• JN International Medical
• Kaketsuken
• LG Life Sciences
• Lupin
• Mitsubishi Tanabe Pharma
• Novavax
• Nuron Biotech
• Panacea Biotec
• Pfizer
• Protein Sciences
• Roche
• SK Chemicals
• Serum Institute of India
• Shenzhen Kangtai Biological Products
• Sinovac Biotech
• Takeda Pharmaceutical
• Vacunas Finlay
• Valeant Pharmaceuticals
• Valneva,
• Zydus Cadila

[Market driver]
• Growing demand among travelers
• For a full, detailed list, view our report

[Market challenge]
• Requires specific storage and distribution system
• For a full, detailed list, view our report

[Market trend]
• Combination vaccines
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Regulatory scenario of vaccines

PART 06: Market landscape
• Market overview
• Five forces analysis

PART 07: Market segmentation by disease type

PART 08: Market segmentation by composition
• Mono vaccines
• Combination vaccines

PART 09: Geographical segmentation
• Travel vaccines market in Americas
• Travel vaccines market in EMEA
• Travel vaccines market in APAC

PART 10: Market drivers
• Growing demand among travelers
• Additional age group approval
• Inclusion in NIP

PART 11: Impact of drivers

PART 12: Market challenges
• Requires specific storage and distribution system
• High risk and cost involved in vaccine development
• Stringent regulatory guidelines

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Combination vaccines
• Increase in R&D activities
• Public–private initiatives

PART 15: Vendor landscape
• Competitive scenario
• Other prominent vendors

PART 16: Key vendor analysis
• GlaxoSmithKline
• Merck
• Pfizer
• Sanofi

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Market share of travel vaccines markets in global pharmaceutical market 2015
Exhibit 03: Market share of travel vaccines markets in global pharmaceutical market, 2015
Exhibit 04: Country/region-specific vaccination
Exhibit 05: Key buying criteria for travel vaccines 2015
Exhibit 06: Impact of key customer segments on market 2015
Exhibit 07: Requirements for a BLA submission
Exhibit 08: Stages of vaccine development to obtain license
Exhibit 09: Processes involved in the vaccine development
Exhibit 10: Regulatory testing of licensed vaccines
Exhibit 11: Market snapshot: Global travel vaccines market
Exhibit 12: Worldwide endemicity of HAV infection
Exhibit 13: Endemicity pattern of HBV across various regions
Exhibit 14: Global travel vaccine market snapshot: Developed and emerging markets 2015
Exhibit 15: Overview of vaccine-related acquisitions (2005-2012)
Exhibit 16: Global travel vaccines market 2015-2020 ($ billions)
Exhibit 17: Few of approved travel vaccines
Exhibit 18: Vaccine recommendation for travelers
Exhibit 19: Five forces analysis
Exhibit 20: Market segmentation of travel vaccines based on disease type 2015
Exhibit 21: Market share of the different types of travel vaccines based on disease type 2015
Exhibit 22: Overview of global travel vaccines market segmentation based on disease type 2015-2020
Exhibit 23: Global travel vaccines market segmentation by composition
Exhibit 24: Details of approved polysaccharide vaccines
Exhibit 25: Snapshot of global travel vaccines market by geography 2015-2020
Exhibit 26: Global travel vaccines market segmentation by geography 2015-2020 ($ millions)
Exhibit 27: Overview of travel vaccines market in Americas
Exhibit 28: Recommended vaccination for travelers to Mexico
Exhibit 29: Recommended vaccination for travelers to Brazil
Exhibit 30: Travel vaccines market in Americas 2015-2020 ($ billions)
Exhibit 31: Overview of travel vaccines market in EMEA
Exhibit 32: Outbreaks of measles in EMEA during 2011
Exhibit 33: Recommended vaccination for travelers to Italy
Exhibit 34: Recommended vaccinations for travelers to France
Exhibit 35: Recommended vaccinations for some travelers to South Africa
Exhibit 36: Travel vaccines market in EMEA 2015-2020 ($ millions)
Exhibit 37: Overview of travel vaccines market in APAC
Exhibit 38: Recommended vaccination for travelers to India
Exhibit 39: Recommended vaccination for travelers to China
Exhibit 40: Travel vaccines market in APAC 2015-2020 ($ millions)
Exhibit 41: Impact of drivers and challenges on global travel vaccines market
Exhibit 42: Impact of drivers
Exhibit 43: A typical cold chain process
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Impact of trends on global travel vaccines market
Exhibit 46: Competitive structure analysis of global travel vaccines market 2015
Exhibit 47: Key vendors: Geographical presence 2015
Exhibit 48: Competitive assessment of vendors
Exhibit 49: GlaxoSmithKline: Key highlights
Exhibit 50: GlaxoSmithKline: Strength assessment
Exhibit 51: GlaxoSmithKline: Strategy assessment
Exhibit 52: GlaxoSmithKline: Opportunity assessment
Exhibit 53: Merck: Key highlights
Exhibit 54: Merck: Strength assessment
Exhibit 55: Merck: Strategy assessment
Exhibit 56: Merck: Opportunity assessment
Exhibit 57: Pfizer: Key highlights
Exhibit 58: Pfizer: Strength assessment
Exhibit 59: Pfizer: Strategy assessment
Exhibit 60: Pfizer: Opportunity assessment
Exhibit 61: Sanofi: Key highlights
Exhibit 62: Sanofi: Strength assessment
Exhibit 63: Sanofi: Strategy assessment
Exhibit 64: Sanofi: Opportunity assessment



【掲載企業】

GlaxoSmithKline, Merck, Pfizer, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Baxter, Beijing Minhai Biotechnology, Bharat Biotech, Bharat Immunologicals and Biologicals, Bio-Med, Seqirus CSL, Crucell, CSL, Dynavax Technologies, Emergent BioSolutions, GlycoVaxyn, GreenSignal Bio Pharma, Hualan Biological Engineering, Imunoloski Zavod, Indian Immunologicals, Janssen Pharmaceuticals, JN International Medical, Kaketsuken, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, Novavax, Nuron Biotech, Panacea Biotec, Pfizer, Protein Sciences, Roche, SK Chemicals, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, Takeda Pharmaceutical, Vacunas Finlay, Valeant Pharmaceuticals, Valneva, Zydus Cadila.

【資料のキーワード】

トラベルワクチン、単価ワクチン、混合ワクチン

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[トラベルワクチンの世界市場2016-2020:単価ワクチン、混合ワクチン] (Global Travel Vaccines Market 2016-2020 / IRTNTR10903)販売に関する免責事項
[トラベルワクチンの世界市場2016-2020:単価ワクチン、混合ワクチン] (Global Travel Vaccines Market 2016-2020 / IRTNTR10903)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆